MML Investors Services LLC lessened its holdings in Hologic, Inc. (NASDAQ:HOLX – Get Rating) by 27.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 21,377 shares of the medical equipment provider’s stock after selling 7,957 shares during the quarter. MML Investors Services LLC’s holdings in Hologic were worth $1,379,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in HOLX. Aviva PLC grew its stake in shares of Hologic by 29.5% in the 3rd quarter. Aviva PLC now owns 288,055 shares of the medical equipment provider’s stock worth $18,585,000 after buying an additional 65,564 shares during the last quarter. Prudential PLC increased its holdings in shares of Hologic by 33.8% during the third quarter. Prudential PLC now owns 67,780 shares of the medical equipment provider’s stock valued at $4,373,000 after acquiring an additional 17,132 shares in the last quarter. Pictet Asset Management SA raised its position in shares of Hologic by 1.6% in the 3rd quarter. Pictet Asset Management SA now owns 315,649 shares of the medical equipment provider’s stock worth $20,366,000 after purchasing an additional 5,069 shares during the last quarter. Skandinaviska Enskilda Banken AB publ boosted its stake in Hologic by 21.0% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 1,230,929 shares of the medical equipment provider’s stock worth $79,420,000 after purchasing an additional 213,791 shares in the last quarter. Finally, Oppenheimer & Co. Inc. increased its stake in Hologic by 2.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 12,665 shares of the medical equipment provider’s stock valued at $817,000 after purchasing an additional 269 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.
Hologic Stock Down 0.7 %
Shares of HOLX stock opened at $79.06 on Thursday. The company has a 50 day simple moving average of $80.35 and a two-hundred day simple moving average of $73.40. The stock has a market cap of $19.49 billion, a P/E ratio of 20.17, a P/E/G ratio of 1.41 and a beta of 1.02. Hologic, Inc. has a 12 month low of $59.78 and a 12 month high of $86.65. The company has a current ratio of 4.21, a quick ratio of 3.50 and a debt-to-equity ratio of 0.55.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on HOLX. Citigroup increased their price target on shares of Hologic from $75.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, February 2nd. Morgan Stanley increased their target price on Hologic from $74.00 to $81.00 and gave the company an “equal weight” rating in a research note on Friday, February 3rd. Cowen boosted their price target on Hologic from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, February 2nd. Wells Fargo & Company increased their price objective on Hologic from $75.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 10th. Finally, SVB Leerink boosted their target price on Hologic from $90.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, February 2nd. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $84.08.
Insider Activity at Hologic
In related news, insider Benjamin Jordan Cohn sold 9,128 shares of the stock in a transaction that occurred on Tuesday, February 7th. The shares were sold at an average price of $85.28, for a total value of $778,435.84. Following the completion of the sale, the insider now directly owns 14,298 shares of the company’s stock, valued at approximately $1,219,333.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.66% of the stock is currently owned by corporate insiders.
About Hologic
Hologic, Inc engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery.
Featured Articles
- Get a free copy of the StockNews.com research report on Hologic (HOLX)
- Jack in the Box Pops On Tasty Results, Robust Outlook
- How Low Can Lowe’s Companies Go?
- Ambarella: An AI Play In The Making
- Terran Orbital’s New $2.4 Billion Contract is a Game Changer
- Wendy’s Price Firms After Sizzling Quarter And Juicy Outlook
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX – Get Rating).
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.
